Neuropeptide Y overflow and metabolism in skeletal muscle arterioles

Journal of Physiology

Volumn 589, Issue 13, 2011, Pages 3309-3318

  Evanson, Kirk W ^a   Stone, Audrey J ^a   Hammond, Allyson L ^a   Kluess, Heidi A ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; NEUROPEPTIDE Y;

AGE; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD FLOW; BLOOD VESSEL CATHETERIZATION; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FLUOROMETRY; GASTROCNEMIUS MUSCLE; GROUPS BY AGE; ISOLATED ARTERY; MALE; MUSCLE BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; QUANTITATIVE STUDY; RAT;

AGING; ANIMALS; ARTERIOLES; DIPEPTIDYL PEPTIDASE 4; FEMALE; MALE; METABOLOME; MUSCLE, SKELETAL; NEUROPEPTIDE Y; RATS; RATS, INBRED F344;

EID: 79959726454     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.209726     Document Type: Article

References (61)

1. Abel PW & Han C (1989). Effects of neuropeptide Y on contraction, relaxation, and membrane potential of rabbit cerebral arteries. J Cardiovasc Pharmacol 13, 52-63.
2. Allen JM, Adrian TE, Polak JM & Bloom SR (1983). Neuropeptide Y (NPY) in the adrenal gland. J Auton Nerv Syst 9, 559-563.
3. Allen JM, Bircham PM, Bloom SR & Edwards AV (1984). Release of neuropeptide Y in response to splanchnic nerve stimulation in the conscious calf. J Physiol 357, 401-408.
4. Buckwalter JB, Hamann JJ & Clifford PS (2005). Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles. J Appl Physiol 99, 2115-2120.
5. Buckwalter JB, Hamann JJ, Kluess HA & Clifford PS (2004). Vasoconstriction in exercising skeletal muscles: a potential role for neuropeptide Y? Am J Physiol Heart Circ Physiol 287, H144-149.
6. Chung KM, Cheng JH, Suen CS, Huang CH, Tsai CH, Huang LH, Chen YR, Wang AH, Hwang MJ & Chen X (2010). The dimeric transmembrane domain of prolyl dipeptidase DPP-IV contributes to its quaternary structure and enzymatic activities. Protein Sci 19, 1627-1638.
7. Clarke J, Benjamin N, Larkin S, Webb D, Maseri A & Davies G (1991). Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man. Circulation 83, 774-777.
8. Donoso MV, Brown N, Carrasco C, Cortes V, Fournier A & Huidobro-Toro JP (1997). Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors. J Neurochem 69, 1048-1059.
9. Durinx C, Lambeir AM, Bosmans E, Falmagne JB, Berghmans R, Haemers A, Scharpe S & De Meester I (2000). Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur J Biochem 267, 5608-5613.
10. Edvinsson L, Ekblad E, Hakanson R & Wahlestedt C (1984). Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol 83, 519-525.
11. Ekblad E, Edvinsson L, Wahlestedt C, Uddman R, Hakanson R & Sundler F (1984). Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept 8, 225-235.
12. Ericsson A, Schalling M, McIntyre KR, Lundberg JM, Larhammar D, Seroogy K, Hokfelt T & Persson H (1987). Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. Proc Natl Acad Sci U S A 84, 5585-5589.
13. Fried G, Terenius L, Hokfelt T & Goldstein M (1985). Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens. J Neurosci 5, 450-458.
14. Glenn TC & Duckles SP (1994). Vascular responses to neuropeptide Y in the rat: effect of age. Aging (Milano) 6, 277-286.
15. Glenn TC, Krause DN & Duckles SP (1997). Vascular responses to neuropeptide Y are greater in female than male rats. Naunyn Schmiedebergs Arch Pharmacol 355, 111-118.
16. Grundemar L & Hogestatt ED (1992). Unmasking the vasoconstrictor response to neuropeptide Y and its interaction with vasodilating agents in vitro. Eur J Pharmacol 221, 71-76.
17. Haim S, Shakhar G, Rossene E, Taylor AN & Ben-Eliyahu S (2003). Serum levels of sex hormones and corticosterone throughout 4- and 5-day estrous cycles in Fischer 344 rats and their simulation in ovariectomized females. J Endocrinol Invest 26, 1013-1022.
18. Han S, Yang CL, Chen X, Naes L, Cox BF & Westfall T (1998). Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction. Am J Physiol Heart Circ Physiol 274, H290-294.
19. Hieble JP, Ruffolo RR Jr & Daly RN (1988). Involvement of vascular endothelium in the potentiation of vasoconstrictor responses by neuropeptide Y. J Hypertens Suppl 6, S239-242.
20. Higuchi H & Yang HY (1986). Splanchnic nerve transection abolishes the age-dependent increase of neuropeptide Y-like immunoreactivity in rat adrenal gland. J Neurochem 46, 1658-1660.
21. Jackson DN, Milne KJ, Noble EG & Shoemaker JK (2005a). Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats. J Physiol 562, 285-294.
22. Jackson DN, Milne KJ, Noble EG & Shoemaker JK (2005b). Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague-Dawley rats. J Physiol 568, 573-581.
23. Joshua IG (1991). Neuropeptide Y-induced constriction in small resistance vessels of skeletal muscle. Peptides 12, 37-41.
24. Karl T, Chwalisz WT, Wedekind D, Hedrich HJ, Hoffmann T, Jacobs R, Pabst R & von Horsten S (2003). Localization, transmission, spontaneous mutations, and variation of function of the Dpp4 (dipeptidyl-peptidase IV; CD26) gene in rats. Regul Pept 115, 81-90.
25. Kirk RE (1995). Experimental Design: Procedures for the Behavioral Sciences. Brooks/Cole Publishing Company, New York
26. Kitlinska J, Lee EW, Li L, Pons J, Estes L & Zukowska Z (2003). Dual role of dipeptidyl peptidase IV (DPP IV) in angiogenesis and vascular remodeling. Adv Exp Med Biol 524, 215-222.
27. Kitlinska J, Lee EW, Movafagh S, Pons J & Zukowska Z (2002). Neuropeptide Y-induced angiogenesis in aging. Peptides 23, 71-77.
28. Kluess HA, Buckwalter JB, Hamann JJ, DeLorey DS & Clifford PS (2006). Frequency and pattern dependence of adrenergic and purinergic vasoconstriction in rat skeletal muscle arteries. Exp Physiol 91, 1051-1058.
29. Lacroix JS (1989). Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa. Acta Physiol Scand Suppl 581, 1-63.
30. Lacroix JS, Stjarne P, Anggard A & Lundberg JM (1988). Sympathetic vascular control of the pig nasal mucosa (2): Reserpine-resistant, non-adrenergic nervous responses in relation to neuropeptide Y and ATP. Acta Physiol Scand 133, 183-197.
31. Lundberg JM, Fried G, Pernow J & Theodorsson-Norheim E (1986a). Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat. Acta Physiol Scand 126, 231-238.
32. Lundberg JM, Fried G, Pernow J, Theodorsson-Norheim E & Anggard A (1986b). NPY - a mediator of reserpine-resistant, non-adrenergic vasoconstriction in cat spleen after preganglionic denervation? Acta Physiol Scand 126, 151-152.
33. Lundberg JM, Pernow J, Franco-Cereceda A & Rudehill A (1987). Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y. J Cardiovasc Pharmacol 10(Suppl 12), S51-68.
34. Lundberg JM, Rudehill A, Sollevi A, Theodorsson-Norheim E & Hamberger B (1986c). Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett 63, 96-100.
35. Lundberg JM, Terenius L, Hokfelt T & Goldstein M (1983). High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 42, 167-172.
36. Maes MB, Lambeir AM, Gilany K, Senten K, Van Der Veken P, Leiting B, Augustyns K, Scharpe S & De Meester I (2005). Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7). Biochem J 386, 315-324.
37. Malmstrom RE (2000). Neuropeptide Y Y1 receptor mediated mesenteric vasoconstriction in the pig in vivo. Regul Pept 95, 59-63.
38. Mentlein R, Dahms P, Grandt D & Kruger R (1993). Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pept 49, 133-144.
39. Mentlein R & Roos T (1996). Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells. Peptides 17, 709-720.
40. Morris JL, Murphy R, Furness JB & Costa M (1986). Partial depletion of neuropeptide Y from noradrenergic perivascular and cardiac axons by 6-hydroxydopamine and reserpine. Regul Pept 13, 147-162.
41. Myers AK, Farhat MY, Vaz CA, Keiser HR & Zukowska-Grojec Z (1988). Release of immunoreactive-neuropeptide by rat platelets. Biochem Biophys Res Commun 155, 118-122.
42. 2-adrenoceptors on microvascular smooth muscle during sympathetic nerve stimulation. Circ Res 68, 232-244.
43. Pernow J, Ohlen A, Hokfelt T, Nilsson O & Lundberg JM (1987). Neuropeptide Y: presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man. Regul Pept 19, 313-324.
44. Pourageaud F & De Mey JG (1998). Vasomotor responses in chronically hyperperfused and hypoperfused rat mesenteric arteries. Am J Physiol Heart Circ Physiol 274, H1301-1307.
45. Scharpe S, De Meester I, Vanhoof G, Hendriks D, van Sande M, Van Camp K & Yaron A (1988). Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine. Clin Chem 34, 2299-2301.
46. Schneider F, Bucher B, Schott C, Andre A, Julou-Schaeffer G & Stoclet JC (1994). Effect of bacterial lipopolysaccharide on function of rat small femoral arteries. Am J Physiol Heart Circ Physiol 266, H191-198.
47. Segal SS (2005). Regulation of blood flow in the microcirculation. Microcirculation 12, 33-45.
48. Stjarne L, Lundberg JM & Astrand P (1986). Neuropeptide Y - a cotransmitter with noradrenaline and adenosine 5'-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study. Neuroscience 18, 151-166.
49. Tainio H, Vaalasti A & Rechardt L (1986). The distribution of sympathetic adrenergic, tyrosine hydroxylase- and neuropeptide Y-immunoreactive nerves in human axillary sweat glands. Histochemistry 85, 117-120.
50. Tatemoto K, Carlquist M & Mutt V (1982). Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296, 659-660.
51. Tessel RE, Miller DW, Misse GA, Dong X & Doughty MB (1993a). Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies. J Pharmacol Exp Ther 265, 172-177.
52. Tessel RE, Miller DW, Misse GA, Dong X & Doughty MB (1993b). Characterization of vascular postsynaptic NPY receptor function and regulation and differential sensitivity of Y1 and Y2 receptor function to changes in extracellular calcium availability and prior in vitro peptide exposure. Neuropeptides 25, 289-298.
53. Thureson-Klein A (1983). Exocytosis from large and small dense cored vesicles in noradrenergic nerve terminals. Neuroscience 10, 245-259.
54. 1-adrenoceptor-mediated contraction through Y1 receptor subtype in rat femoral artery. J Cardiovasc Pharmacol 42(Suppl 1), S33-37.
55. Turturro A, Witt WW, Lewis S, Hass BS, Lipman RD & Hart RW (1999). Growth curves and survival characteristics of the animals used in the Biomarkers of Aging Program. J Gerontol A Biol Sci Med Sci 54, B492-501.
56. Varndell IM, Polak JM, Allen JM, Terenghi G & Bloom SR (1984). Neuropeptide tyrosine (NPY) immunoreactivity in norepinephrine-containing cells and nerves of the mammalian adrenal gland. Endocrinology 114, 1460-1462.
57. Wahlestedt C, Grundemar L, Hakanson R, Heilig M, Shen GH, Zukowska-Grojec Z & Reis DJ (1990). Neuropeptide Y receptor subtypes, Y1 and Y2. Ann N Y Acad Sci 611, 7-26.
58. Wahlestedt C, Yanaihara N & Hakanson R (1986). Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept 13, 307-318.
59. Williams DA & Segal SS (1993). Feed artery role in blood flow control to rat hindlimb skeletal muscles. J Physiol 463, 631-646.
60. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E & Grant DS (1998). Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83, 187-195.
61. Zukowska Z, Pons J, Lee EW & Li L (2003). Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? Can J Physiol Pharmacol 81, 89-94.